Literature DB >> 9267971

Extrapyramidal signs in patients with probable Alzheimer disease.

O L Lopez1, S R Wisnieski, J T Becker, F Boller, S T DeKosky.   

Abstract

OBJECTIVE: To examine whether extrapyramidal signs (EPSs) were associated with more rapid progression of Alzheimer disease (AD).
DESIGN: Cross-sectional with longitudinal follow-up and the likelihood of arriving at 4 end points: Mini-Mental State Examination score of less than 9, Blessed Dementia Rating Scale score for activities of daily living of 15 or more, institutionalization, and death using a proportional hazard model with 6 variables: overall EPSs, bradykinesia, tremors, abnormal gait, cogwheel rigidity, and postural instability.
SETTING: Multidisciplinary behavioral neurology research clinic. PATIENTS: We examined the individual EPS characteristics of 164 patients with mild-moderately probable AD, free of neuroleptic medication, participating in a longitudinal study of dementia.
RESULTS: Patients with AD with EPSs (n= 51 [31%]) were older (P>.001) and had lower Mini-Mental State Examination scores (P=.003) than those without EPSs at study entry. Bradykinesia was present in 35 (69%) of the 51 patients with EPSs, abnormal gait in 18 (35%), rigidity in 10 (20%), postural instability in 10 (20%), tremors in 7 (14%), and oral-mandibular dyskinesia in 2 (4%). Using proportional hazard analysis with time-dependent covariates for overall EPSs and individual EPSs, adjusted by age at study entry, education, Mini-Mental State Examination score, and Blessed Dementia Rating Scale score for activities of daily living, the development of EPSs was associated with time to institutionalization (P<.001) but not with cognitive (eg, Mini-Mental State Examination score <9) or functional (eg, Blessed Dementia Rating Scale score > or = 15) decline or death. However, when we examined severity of the EPSs, as measured by the New York University Parkinson's Disease Scale, the development of EPSs was associated with functional decline (P=.005). Of the individual EPSs, rigidity predicted death (P<.001) and institutionalization (P=.03), whereas tremors predicted functional decline (P=.02).
CONCLUSIONS: In this cohort, the presence or absence of EPSs is related to time to institutionalization, but not to severe cognitive or functional impairment or death. However, when severity of the extrapyramidal phenomenon is taken into account, EPSs are related to functional decline. Further, it appears that a subgroup of patients with AD with EPSs, where cogwheel rigidity and tremors are the core signs, can have a worse outcome.

Entities:  

Mesh:

Year:  1997        PMID: 9267971     DOI: 10.1001/archneur.1997.00550200033007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

1.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

2.  Extrapyramidal signs before and after diagnosis of incident Alzheimer disease in a prospective population study.

Authors:  Florence Portet; Nikolaos Scarmeas; Stephanie Cosentino; Elisabeth P Helzner; Yaakov Stern
Journal:  Arch Neurol       Date:  2009-09

3.  Dementia with Lewy Bodies versus Alzheimer's Disease and Parkinson's Disease Dementia: A Comparison of Cognitive Profiles.

Authors:  Kyung Won Park; Hyun Sook Kim; Sang-Myung Cheon; Jae-Kwan Cha; Sang-Ho Kim; Jae Woo Kim
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

4.  Upper and lower extremity motor performance and functional impairment in Alzheimer's disease.

Authors:  Liesi E Hebert; Julia L Bienias; Judith J McCann; Paul A Scherr; Robert S Wilson; Denis A Evans
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-05-19       Impact factor: 2.035

Review 5.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

6.  Delusions and hallucinations are associated with worse outcome in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Marilyn Albert; Georgios Hadjigeorgiou; Alexandros Papadimitriou; Bruno Dubois; Maria Sarazin; Davangere Devanand; Lawrence Honig; Karen Marder; Karen Bell; Domonick Wegesin; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2005-10

Review 7.  Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.

Authors:  Luis Hernandez; Asli Ozen; Rodrigo DosSantos; Denis Getsios
Journal:  Pharmacoeconomics       Date:  2016-07       Impact factor: 4.981

8.  A Case of Biopsy-proven Early-onset Alzheimer's Disease with Hemiparkinsonism.

Authors:  Eun Jung Choi; Hyun Bang; Joo Hyuk Im; Sun Joo Chung; Jae-Hong Lee
Journal:  J Clin Neurol       Date:  2005-04-30       Impact factor: 3.077

9.  Motor signs during the course of Alzheimer disease.

Authors:  N Scarmeas; G M Hadjigeorgiou; A Papadimitriou; B Dubois; M Sarazin; J Brandt; M Albert; K Marder; K Bell; L S Honig; D Wegesin; Y Stern
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

10.  Disruptive behavior as a predictor in Alzheimer disease.

Authors:  Nikolaos Scarmeas; Jason Brandt; Deborah Blacker; Marilyn Albert; Georgios Hadjigeorgiou; Bruno Dubois; Davangere Devanand; Lawrence Honig; Yaakov Stern
Journal:  Arch Neurol       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.